Niloufar Khojandi

Niloufar Khojandi, PhD, is a Clinical Scientist at Hologic, Inc. since December 2024, with prior experience as a Scientist and Associate Scientist at Turnstone Biologics from May 2022 to December 2024. Niloufar was a Researcher PhD Candidate at St. Louis University School of Medicine from July 2017 to May 2022, focusing on the impact of obesity on immunotherapy outcomes in cancer patients and exploring novel treatment combinations. Additional experience includes a summer internship analyzing COVID-19 data at the Missouri Department of Health and Senior Services in 2020, and a Research Assistant role at Washington University in St. Louis. Niloufar holds a PhD in Immunology from Saint Louis University School of Medicine and multiple degrees in Biology, Chemistry, and an undergraduate degree in Chemistry from Sharif University of Technology.